ArticleDelayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs
References (42)
Glutamate neurotoxicity and diseases of the nervous system
Neuron
(1988)- et al.
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Brain Res.
(1990) - et al.
Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways
Neuron
(1993) - et al.
Anti-inflammatory drugs and Alzheimer disease
Lancet
(1990) - et al.
Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease
Neurobiol. Aging
(1990) - et al.
Completeness of prescription recording in outpatient medical records from a health maintenance organization
J. Clin. Epidemiol.
(1994) Enhancement by histamine of NMDA-mediated synaptic transmission in the hippocampus
Science
(1993)- et al.
Clinical genetics and genetic counseling in Alzheimer's disease
Ann. Intern. Med.
(1991)New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause
Neurobiol. Aging
(1994)
The use of twin cohorts for research in Alzheimer's disease
Neurology
Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study
Neurology
Age-dependent expression of familial risk in Alzheimer's disease
Am. J. Epidemiol.
Case-control studies of environmental influences in diseases with genetic determinants, with an application to Alzheimer's disease
Am. J. Epidemiol.
Epidemiology of Alzheimer's disease
Epidemiol. Rev.
Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease
Nature Genet.
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
Science
Regression models and tables (with discussion)
J. R. Stat. Soc. Series B
Complement activation in amyloid plaques in Alzheimer's dementia
Virchows Arch. [B]
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Nature
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
Cited by (422)
Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study
2023, Journal of Psychosomatic ResearchAlzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
2023, Ageing Research ReviewsNaproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism
2022, European Journal of PharmacologyCitation Excerpt :Therefore, a therapeutic intervention targeting neuroinflammation, particularly in early disease processes (McGeer et al., 1996; Stewart et al., 1997; Vlad et al., 2008), seems to potentially restrain AD's further progression. NSAID use is associated with a lower risk of developing AD in a range of ethnodemographic populations (Breitner et al., 1995; Côté et al., 2012; Fischer et al., 2008; Landi et al., 2003; Stewart et al., 1997; Szekely et al., 2008; Veld et al., 2001; Vlad et al., 2008) besides various preclinical studies (Lim et al., 2000; Weggen et al., 2001; Yan et al., 2003). Importantly, a greatly reduced risk of AD was noticed in rheumatoid arthritis patients on long-term NSAIDs (Mcgeer et al., 1990).
Does Alzheimer's disease stem in the gastrointestinal system?
2021, Life SciencesCitation Excerpt :However, the results are paradoxical. There are two cross-sectional studies that indicated an association between using H2RA medications and a lower risk of AD development [189,190]. The hypothesis started from the assumption that reducing the neurotransmission of histamine, as an important participator in the mechanisms of forgetting, could improve cognition performance [191].